Patient perspectives following pharmacogenomics results disclosure in an integrated health system

Pharmacogenomics
Amy A LemkeHenry M Dunnenberger

Abstract

To assess patient perceptions and utilization of pharmacogenomics (PGx) testing in an integrated community health system. Fifty-seven patients completed an online survey assessing their experiences with PGx testing offered through two methods: a designated PGx clinic or direct access in-home testing. The majority of participants perceived PGx testing as helpful in their healthcare and reported understanding their results. Some had concerns about privacy and discrimination; most lacked familiarity with the Genetic Information Nondiscrimination Act. There were no significant differences in views between participants tested through either model. Participants reported value in both methods of PGx testing. Patient experiences, understanding and result utilization will play an important role in informing future development and implementation of PGx programs.

References

Nov 17, 2001·JAMA : the Journal of the American Medical Association·K A PhillipsW Sadee
Sep 17, 2004·Nature Reviews. Genetics·Andrew WebsterAndrew Smart
Feb 16, 2011·The Pharmacogenomics Journal·S B HagaR Agans
Nov 4, 2011·Genetic Testing and Molecular Biomarkers·Susanne B HagaJulianne M O'Daniel
Aug 31, 2012·Frontiers in Pharmacology·E W Chua, M A Kennedy
Jan 12, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Teri A ManolioGeoffrey S Ginsburg
Oct 30, 2013·Pharmacotherapy·Haridarshan N PatelA Simon Pickard
Jun 10, 2014·Pharmacogenetics and Genomics·Sinead CuffeGeoffrey Liu
Jul 22, 2014·Pharmacogenomics and Personalized Medicine·Katherine A Johansen Taber, Barry D Dickinson
Oct 9, 2014·Annual Review of Pharmacology and Toxicology·Henry M DunnenbergerMary V Relling
Nov 12, 2015·Pharmacogenomics·Susanne B HagaNancy M Allen LaPointe
Dec 5, 2015·Personalized Medicine·Kim M UnertlJosh F Peterson
Mar 2, 2016·Annals of Internal Medicine·Cathelijne H van der WoudenUNKNOWN Impact of Personal Genomics Study Group
Sep 1, 2016·European Journal of Human Genetics : EJHG·Cathelijne H van der WoudenHenk-Jan Guchelaar
Sep 1, 2016·European Journal of Human Genetics : EJHG·Ritika KapoorYik-Ying Teo
Sep 21, 2016·Pharmacogenomics·Susanne B HagaGeoffrey S Ginsburg
Sep 23, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Deanna Alexis CarereRobert C Green
Oct 8, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Di DongEric Finkelstein
Oct 26, 2016·The Pharmacogenomics Journal·S J BielinskiV L Roger
Nov 20, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Henry M DunnenbergerJanardan Khandekar
Dec 13, 2016·Trends in Pharmacological Sciences·Diane M KorngiebelWylie Burke
Dec 17, 2016·Clinical Pharmacology and Therapeutics·R P McKillipP H O'Donnell
Jan 6, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Janet E OlsonSuzette J Bielinski
Jan 17, 2017·Clinical Pharmacology and Therapeutics·J A LuzumUNKNOWN Pharmacogenomics Research Network Translational Pharmacogenetics Program
Feb 19, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marc B RosenmanMichael T Eadon
Feb 19, 2017·Pharmacology & Therapeutics·Ge Zhang, Daniel W Nebert
Feb 27, 2017·Pharmaceutical Research·Mafalda M DiasRoss A McKinnon
Mar 8, 2017·Pharmacogenetics and Genomics·Yee Ming LeePeter H O'Donnell
Apr 9, 2017·Clinical Pharmacology and Therapeutics·P J CaraballoR M Weinshilboum
Sep 28, 2017·Expert Review of Pharmacoeconomics & Outcomes Research·Ann M Moyer, Pedro J Caraballo
Sep 1, 2016·Personalized Medicine·Nonie S AroraUNKNOWN MedSeq Project

❮ Previous
Next ❯

Citations

Jul 28, 2020·Journal of Clinical Medicine·Meghan J ArwoodJohn G Gums
Jun 11, 2020·Healthcare·John StegelmeierJared Barrott
Feb 8, 2019·Pharmacogenomics·Sarah Jones
Apr 29, 2020·Journal of Personalized Medicine·Tara SchmidlenLaura B Scheinfeldt
May 28, 2020·The Pharmacogenomics Journal·Muhammad Adzran Che MustapaZurina Mahadi
Jun 26, 2020·Pharmacopsychiatry·Ina LikoYee Ming Lee
Oct 5, 2019·The Medical Clinics of North America·Dyson T WakePeter J Hulick
Jan 20, 2021·Pharmacogenomics·Dyson T WakeHenry M Dunnenberger
Feb 18, 2021·Genetic Testing and Molecular Biomarkers·Amy A LemkePeter J Hulick
Apr 15, 2021·Pharmacogenomics·Stephani L StancilSusan Abdel-Rahman
Jun 9, 2021·Clinical Pharmacology and Therapeutics·Jasmine A LuzumLarisa H Cavallari
Aug 9, 2021·Clinical Pharmacology and Therapeutics·Dyson T WakeHenry M Dunnenberger
Oct 3, 2021·Human Genetics·Evangelia Eirini TsermpiniGeorge P Patrinos

❮ Previous
Next ❯

Software Mentioned

PGx
SPSS
GINA
SurveyMonkey

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.